ESPAD Survey: Vaping Prevalent among European Students

Sep.01.2022
ESPAD Survey: Vaping Prevalent among European Students
The ESPAD project investigates alcohol, tobacco, and drug use among 15-16 year old students in 35 European countries.

The European School Survey Project on Alcohol and Other Drugs (ESPAD) is the largest survey of alcohol, tobacco, and illegal drug use among 15-16 year old students in 35 European countries. It is coordinated by the Institute of Clinical Physiology of the National Research Council of Italy (CNR-Ifc). Using standardized methods since 1999, this survey is able to assess changes in young people's habits and has recently garnered interest from the World Health Organization.


Data shows that traditional tobacco cigarette use is declining among adolescents, possibly due to prevention and comparison policies implemented in many countries. However, concerning data about electronic cigarette use has emerged as a worrying trend. In response, the epidemiology and health services research department of CNR-Ifc conducted a study titled "Electronic Cigarette Use and Conventional Smoking Among European Students: Results From the 2019 ESPAD Survey," published in the journal Addiction, to analyze how tobacco control policies impact these habits.


In 2019, a study of approximately 100,000 ESPAD students found that 40.6% had tried traditional cigarettes at least once, with 19.3% currently being smokers. The percentage of smokers varied from 5.1% in Iceland to 32.4% in Italy. On the other hand, 37.8% of students reported trying e-cigarettes, with 12.4% currently using them (13.4% in Italy). According to the study's author, Sonia Cerrai, it can be assumed that young people's attitudes towards new smoking habits will continue to grow, due to the ease of access and perception of low risk.


In the ten countries analyzed, the use of electronic cigarettes has surpassed traditional smoking," stated Cerrai. "While electronic cigarettes may not necessarily contain nicotine, these tech products that are highly attractive to young people and very young individuals are frequently used in conjunction with traditional cigarettes, with usage ranging from 2% in Cyprus to 15% in Monaco (8.9% in Italy) within the sample.


However, implementing tobacco control policies by the government can also contribute to preventing smoking. "In this analysis, we used the Tobacco Control Scale index, which scores policies based on the measures taken," explained Cerrai. "We also considered some specific factors in our analysis: price increases showed a clear association with decreased use of two smoking methods. More spending on information campaigns and cessation programs only correlated with traditional smoking, while measures to prohibit the promotion and advertising of electronic devices were stricter.


According to researchers, the marketing for new devices emphasizes safety by reducing the risks associated with tobacco smoke exposure. However, this complete change in consumption patterns could lead to distractions for young people, who are also familiar with prevention initiatives and programs implemented in the past 20 years.


Statement: 1. The content of this article is compiled from third-party information, provided solely for industry exchange and learning purposes. 2. This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity and accuracy of the article's content. The compilation of this article is only for industry exchange and research purposes. 3. Due to limitations in the compilation process, the compiled article may not fully match the original text. Please refer to the original text for accuracy. 4. 2FIRSTS fully aligns with the Chinese government on any statements and positions related to domestic, Hong Kong, Macau, Taiwan, and foreign issues. 5. Copyright for compiled information belongs to the original media and author. Please contact us for removal if there is any infringement.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Imperial Brands' acquisition of Swedish Helwit owner Yoik Group AB has highlighted the professional-services firms supporting cross-border oral nicotine M&A. Latham & Watkins and KPMG advised Imperial, while PwC and TM & Partners advised Yoik. KPMG also appeared on Imperial's acquisition of Black Buffalo earlier in 2026, while PwC played an extensive role in KT&G's acquisition of Swedish nicotine-pouch company Another Snus Factory. Imperial's public disclosures put the global modern oral nicotine delivery market at approximately £8.8 billion in retail sales and 23.5 billion pouches in 2024
Sep.20
Product | JT Launches Three Autumn-Limited Ploom Tobacco Sticks in Japan Across EVO, MEVIUS and CAMEL Brands
Product | JT Launches Three Autumn-Limited Ploom Tobacco Sticks in Japan Across EVO, MEVIUS and CAMEL Brands
Japan Tobacco Inc. (JT) launched three limited-edition autumn tobacco sticks for its Ploom heated tobacco devices in Japan on October 16, 2026, under the EVO, MEVIUS and CAMEL brands. All three are regular tobacco variants with seasonal packaging. Each pack contains 20 sticks, priced at ¥620, ¥590 and ¥570, respectively, including tax. The products are compatible with all Ploom devices and are sold in limited quantities exclusively through the CLUB JT online store while supplies last.
product
Oct.20
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
On September 16, 2Firsts hosted a China-focused industry forum during InterTabac in Dortmund, bringing together more than 30 participants from North America, Europe, India, South Korea and other markets. The session covered traditional tobacco, next-generation products, exports, technology, regulation and supply chains, while examining how China’s tobacco sector operates, where its transformation may be heading, and why its growing role matters increasingly to companies across the global tobacco and nicotine industry.
Sep.21
Snowplus Enters Japan’s FamilyMart Network With Zero-Nicotine NEO Line and Kishidan Campaign
Snowplus Enters Japan’s FamilyMart Network With Zero-Nicotine NEO Line and Kishidan Campaign
Snowplus distributor H&S said the zero-nicotine, zero-tar NEO vaping line will begin rolling out across FamilyMart stores in Japan from September 14, 2026, excluding some locations. The DASH line will also be sold at selected FamilyMart stores in southern Kyushu and Okinawa. Snowplus simultaneously named Japanese rock band Kishidan as a brand ambassador, combining convenience-store distribution with a broader consumer marketing push in Japan.
Sep.15
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04